Jpmc change order notice - narcan

The Chief Procurement Office for General Services (CPO-GS) for the State of Illinois is executing a change order with Emergent Devices Inc. to extend an existing master agreement for Narcan 4mg Nasal Spray for six months through December 31, 2026, with a due date of June 30, 2026. This is the fourth extension of the underlying indefinite-quantity joint purchase master contract (JPMC) originally established April 23, 2021 and originally procured via JPMC Participation with MMCAP. The master agreement enables governmental units and qualified not-for-profit entities to purchase Narcan on an as-needed basis through cooperative purchasing.

As an indefinite-quantity contract, there is no not-to-exceed value specified. Current spending on the master blanket purchase order totals approximately $65 million over the 61-month contract term, averaging approximately $1.1 million per month statewide. The estimated value of this six-month extension is $9 million, accounting for potential volume increases by ordering agencies.

The contract extension aligns with the amended end date of the MMCAP Infuse master contract MMS2000303 and maintains uninterrupted access to this critical, life-saving medication at a competitively priced rate leveraging volume-based discounts. The State Purchasing Officer, Unified Procurement Program Representative, and Chief Procurement Officer approved the extension on June 10, 2026.